Drug Topics
SEPTEMBER 26, 2023
Pharmacists at nearly 2 dozen CVS pharmacy locations called out sick Thursday and Friday to protest recent corporate decisions they say put patients at risk of serious harm.
PharmaVoice
SEPTEMBER 26, 2023
From COTA’s large datasets and AI model assistants to a company guiding patients through cancer care, AI can help — but it’s a long way from human-free.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
SEPTEMBER 26, 2023
A new study in the New England Journal of Medicine found no significant difference in the number of children who received a T1D diagnosis between those with and without a SARS-CoV-2 infection.
Pharmacy Times
SEPTEMBER 26, 2023
Tune in to this episode of the Independent Rx Forum to gain a comprehensive understanding of the enduring significance of independent and community pharmacies.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
SEPTEMBER 26, 2023
A significantly decreased risk of endometrial cancer was reported among participants with a history of pregnancy compared to those nulliparous.
Pharmacy Times
SEPTEMBER 26, 2023
In clinical trials, lecanemab showed a reduction of amyloid beta plaque in patients with Alzheimer disease.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
SEPTEMBER 26, 2023
Most patients had improved clinical response within 90 days of receiving the dendritic cell vaccine and ASCT.
STAT
SEPTEMBER 26, 2023
Jobs in health care are known to be challenging for workers’ mental health. But the mental health toll can be especially burdensome for registered nurses, health technicians, and health care support workers, who are at a higher risk of suicide compared to the general population, according to a study published on Tuesday in the Journal of the American Medical Association that looked at a nationally representative cohort of about 1.84 million employed people (both within the health care fie
Pharmacy Times
SEPTEMBER 26, 2023
Researchers find correlation of increased anaphylaxis with the use of a-tryptase.
STAT
SEPTEMBER 26, 2023
Extending patent protection doesn’t just stretch a drug’s profits — in some cases, doing so can lead to its most significant revenue period, according to a recent analysis published by the Initiative for Medicines, Access & Knowledge, or I-MAK, a nonprofit advocating for drug pricing reforms. The organization looked at four blockbuster drugs — Humira, Avastin, Rituxan, and Lantus — that had biosimilars launched between 2019 and 2023.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
SEPTEMBER 26, 2023
Functional exercise resulted in more improvements for individuals with PCC compared to standard treatment, although individuals must be monitored for adverse events.
STAT
SEPTEMBER 26, 2023
WASHINGTON — Almond milk — not almond beverage, almond drink, or even almond juice — appears here to stay. There’s few issues in the food world that generate as much vitriol as the debate over what to call nut, oat, and other plant-based alternatives to cow’s milk.
Pharmacy Times
SEPTEMBER 26, 2023
This disease can, at the very least, help researchers to “identify” the floodgates to definitive tests and therapies for complex psychological and neurological diseases, expert says.
STAT
SEPTEMBER 26, 2023
Patriarchy isn’t a word that Ophira Ginsburg expected to be at the center of her work as a cancer researcher but, like an infection, it was invading her everyday work as a medical oncologist. There were times when she saw people treat women’s lives and health with cruel indifference. There were times when she saw women who struggled to access care because of violence or social obligations or stigma.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
SEPTEMBER 26, 2023
The Flagship-backed biotech believes the secret to more precise drug delivery lies in the nanoparticles of plants and fungi.
STAT
SEPTEMBER 26, 2023
The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid. “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital.
pharmaphorum
SEPTEMBER 26, 2023
Post-pandemic reality hits digital health hard Mike.
STAT
SEPTEMBER 26, 2023
Results released Tuesday from an early study of an autoimmune disease drug from Roivant Sciences’ Immunovant showed the treatment could reduce the levels of a key immune marker in the blood, a promising signal. The results are only from a Phase 1 trial, but were anticipated because they were the first-in-human outcomes being reported for the antibody drug, IMVT-1402.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
SEPTEMBER 26, 2023
Virgin Pulse and benefits administrator HealthComp are set to merge in a $3 billion deal that aims to drive lower costs and improve outcomes for employers. | Virgin Pulse and benefits administrator HealthComp are set to merge in a $3 billion deal that aims to drive lower costs and improve outcomes for employers.
STAT
SEPTEMBER 26, 2023
Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price Competition and Innovation Act of 2009 created a regulatory pathway for biosimilar medicine review in the U.S., 37 biosimilars have come to market offering the potential to increase patient choice and cost savings.
Fierce Healthcare
SEPTEMBER 26, 2023
Payers, providers are cautiously optimistic about their value-based care efforts.
STAT
SEPTEMBER 26, 2023
Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion. Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept , in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price.
Fierce Healthcare
SEPTEMBER 26, 2023
Expect premiums, benefits and plan choices for Medicare Advantage (MA) and the Medicare Part D prescription drug program to look similar in 2024, the Centers for Medicare & Medicaid Services (C | CMS announced that nearly three-quarters of MA plan beneficiaries will not see their premiums rise.
STAT
SEPTEMBER 26, 2023
WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress. The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid.
Drug Store News
SEPTEMBER 26, 2023
The Dirty Pillows line, inspired by an outtake from a Coolidge’s previous e.l.f commercial shoot, will be available online.
STAT
SEPTEMBER 26, 2023
Ionis Pharmaceuticals, a California biotech that has spearheaded the development of RNA-targeting medicines, announced on Tuesday that its drug against familial chylomicronemia syndrome, a rare and serious disease that prevents the body from breaking down fats, succeeded in a late-stage clinical trial. The Phase 3 trial, dubbed Balance, enrolled 66 adults who were randomly divided into three groups and given a monthly injection of placebo or one of two doses of olezarsen, the company’s ex
Fierce Healthcare
SEPTEMBER 26, 2023
Digital health company Waltz Health is cracking into the payer market by inking its first partnership. | Digital health company Waltz Health is cracking into the payer market by inking its first partnership.
STAT
SEPTEMBER 26, 2023
If you’re surprised Elevance Health is having trouble buying a not-for-profit Blues plan, you haven’t been paying attention. The insurance behemoth hasn’t pulled off such a deal in almost 20 years. Elevance’s announcement that it’s pausing its $2.5 billion bid to buy Blue Cross and Blue Shield of Louisiana follows strong pushback amid concerns about higher prices, fairness to members, and uncertainty over what would happen with the billions in proceeds.
Drug Store News
SEPTEMBER 26, 2023
Walmart is now introducing Walmart Discovered, a Roblox activation designed to streamline the discovery of virtual items and creators on the metaverse platform.
STAT
SEPTEMBER 26, 2023
Hello, everyone, and nice to see you again after we engaged in an extended respite. We took the opportunity to recharge and reflect, but now, of course, have returned to the usual routine of deadlines and calls and the like. So time to fire up the coffee kettle and quaff a few cups of stimulation. We are starting today with glazed doughnut, since one can never be too sweet, yes?
pharmaphorum
SEPTEMBER 26, 2023
Takeda joins PIKfyve ALS push with AcuraStem deal Phil.
European Pharmaceutical Review
SEPTEMBER 26, 2023
Resminostat (Kinselby) has been clinically proven to postpone disease progression, new data from one of the largest clinical trials in cutaneous T-cell lymphoma (CTCL) to date has revealed. The treatment is an oral small molecule class I, IIb and IV histone deacetylase (HDAC) inhibitor. Data from the RESMAIN resminostat study Findings from the RESMAIN study of the maintenance therapy could significantly change clinical practice in advanced CTCL, according to the company.
pharmaphorum
SEPTEMBER 26, 2023
Valo Health bags $2.7bn AI partnership with Novo Nordisk Phil.
Expert insights. Personalized for you.
618 
Let's personalize your content